Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-20

Clinical Trial Update: Gastrointestinal Integrity After Naproxen + Rebamipide Versus Naproxen + Placebo [Phase 1]

View source ↗

Summary

Phase 1 trial comparing naproxen plus rebamipide vs naproxen plus placebo to assess gastrointestinal integrity; results were posted in March 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naproxen (Naproxen)
  • Rebamipide (rebamipide)

Snippet

Sponsor: Biolab Sanus Farmaceutica | Conditions: Gastrointestinal Lesions | Phase 1 | Status: COMPLETED | Results posted: 2017-03-20